Dr. Reddy's Laboratories, Inc. recalls Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's
Dr. Reddy's recalls 300 mg Clopidogrel tablets due to failed dissolution testing at 18 months. Affected lots may not release medication properly.
Lower-risk recall
Failed dissolution specification -Two additional lots being recalled due to Out-of-Specification results observed for dissolution at 18th month stability testing.
Contact the company & request your remedy
What happened, in plain English
Dr. Reddy's is recalling 300 mg Clopidogrel tablets that failed dissolution testing at 18 months. This means the medication might not work as intended if taken. Read more at govinfonow.com/recall/39375-dr-reddy-s-clopidogrel-tablets-recall-failed-dissolution-testing.
Source Summary by GovInfoNow · govinfonow.com/recall/39375-dr-reddy-s-clopidogrel-tablets-recall-failed-dissolution-testing · Updated October 5, 2026 · FDA enforcement record: FDA #D-0294-2019
Cite this page
“Dr. Reddy's Clopidogrel Tablets Recall: Failed Dissolution Testing.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39375-dr-reddy-s-clopidogrel-tablets-recall-failed-dissolution-testing. Based on FDA recall #D-0294-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0294-2019%22&limit=1).
Why it’s dangerous
The tablets failed to dissolve properly during stability testing at 18 months. This could mean the medication doesn't release the active ingredient correctly when taken, potentially reducing effectiveness.
Who’s affected
People prescribed Clopidogrel who received these specific lots from Dr. Reddy's. Those with heart conditions or blood clot risks are most affected.
How to tell if you have this one
Check for the lot numbers T700423 (expiring 08/2019) or T800310 (expiring 03/2020) on the blister pack. The product is a prescription-only 300 mg Clopidogrel tablet.
- Brand
Dr. Reddy's- Category
Drug
What to do — step by step
Check Product Details
Look for the lot numbers T700423 (expiring 08/2019) or T800310 (expiring 03/2020) on the blister pack.
Questions people ask
Why is this medication being recalled?
The tablets failed dissolution testing at 18 months, meaning they may not release medication properly.
Is there a remedy for this recall?
The recall record does not specify a remedy.
What should I do if I have these tablets?
Check the lot numbers on the blister pack. If they match T700423 or T800310, contact your doctor or pharmacist for advice.
Contact Dr. Reddy's
We’ve drafted a message you can send Dr. Reddy's to request your refund or repair — edit it as you like.
Subject: Recall D-0294-2019 — Dr. Reddy's Dr. Reddy's Hello, I own a Dr. Reddy's that is covered by recall D-0294-2019 from Dr. Reddy's. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0294-2019 (December 10, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0294-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
